September 13, 2023

CDC Recommends Updated 2023-2024 COVID-19 Vaccines for Everyone 6 Months and Older

CDC now recommends the newly-authorized 2023-2024 monovalent COVID-19 vaccines for everyone age 6 months and older, to help protect them against severe COVID-19 illness this fall and winter:

Individuals 5 years of age and older (regardless of previous vaccination) are recommended to receive a single dose of an updated mRNA COVID-19 vaccine
Individuals 6 months through 4 years of age who have previously been vaccinated are recommended to receive one or two doses of an updated mRNA COVID-19 vaccine, depending on history and timing of previous COVID-19 vaccine doses.
Unvaccinated individuals 6 months through 4 years of age are recommended to receive three doses of the updated Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated Moderna COVID-19 Vaccine.
An updated COVID-19 vaccine dose can be given at least 2 months after receipt of a prior COVID-19 vaccine dose.
Note: FDA is still reviewing the 2023-2024 Novavax vaccine. The original formulation of Novavax vaccine may still be administered if it is determined that the individual should not wait for a 2023-2024 Novavax COVID-19 vaccine or receive a 2023-2024 mRNA COVID-19 vaccine.

Bivalent mRNA COVID-19 Vaccines Are No Longer Authorized

Remove bivalent mRNA COVID-19 vaccines from your inventory. See table below for a listing of COVID-19 bivalent vaccines that should be removed from your inventory. For additional information, see IIS COVID-19 Vaccine Related Code I CDC.

To minimize the risk of vaccine administration errors, providers should:

Remove all bivalent mRNA COVID-19 vaccines from storage units regardless of expiration dates
Dispose of all bivalent mRNA COVID-19 vaccine vials in pharmaceutical waste containers or comingled pharmaceutical/sharps waste containers in accordance with local regulations and practice protocols for the disposal of regulated medical waste.
- BAP and VFC Providers should report all disposed inventory as wastage in myCAvax as reason “other.” Inactive providers should be able to report waste for themselves on September 13, 2023.
- Federal agencies and pharmacies can use Vaccine Provider Ordering Portal (VPoP) to generate wastage files to upload into VTrckS.

Ordering

As a reminder, ordering for Moderna and Pfizer bivalent vaccines was turned off on 9/11/2023, following the authorization of updated vaccines. Novavax vaccine will be available until 8:00 p.m. ET on 9/12/2023. Providers may continue to administer this vaccine if it is determined that an individual should not wait for a 2023-2024 Novavax COVID-19 vaccine.

Preordering for the updated Moderna and Pfizer COVID-19 vaccines for LHD clinics has been closed as of 12PM yesterday, September 12.

Ordering for Moderna’s pediatric vaccine for children 6m-11y and Novavax’s presentation for children and adults aged 12y+ will be available at a future date. More information will be forthcoming.

Reminder - How to Obtain Updated Vaccine

In the commercial market:
- Moderna: Providers can order through McKesson, Cardinal, and AmeriSource Bergen distributors or directly with Moderna at www.modernadirect.com and 1-866-MODERNA / 1-866-663-3762.
- Pfizer: Providers may work with wholesalers or directly with Pfizer for minimum quantities at https://primecontracts.pfizer.com and 1-800-666-7248.
- Novavax: Novavax will be available to order through your dedicated distributor. For more information on product purchasing, email Novavax CA regional Business Director, Nidal Naser at nnaser@novavax.com.
Bridge Access Program Providers: may still utilize myCAvax for their vaccine needs.
California Vaccines for Children Program: may soon be able to order Pediatric COVID-19 vaccines for VFC-eligible patients through myVFCVaccines.

‌Subscribe to EZIZ Emails

EZIZ.org

‌‌California Department of Public Health | Immunization Branch
850 Marina Bay Pkwy
Richmond CA 94804
View In Browser

850 Marina Bay Parkway, Bldg P Richmond CA 94804

Unsubscribe